A retrospective cohort study links higher tigecycline trough blood concentrations to a sharply increased risk of drug-induced hypofibrinogenemia in intensive care patients.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.